Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

AZD-1236

Generic Name: AZD-1236

Drug Type: Small Molecule

Chemical Formula: C_₁₅H_₁₉ClN_₄O_₅S

CAS Number: 459814-89-2

Unique Ingredient Identifier: B4OQY51WZS

Overview

AZD1236 has been used in trials studying the basic science and treatment of Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Background

AZD1236 has been used in trials studying the basic science and treatment of Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis

Phase 2

Withdrawn

Posted: 2008/12/19

Sponsor:AstraZeneca

ID:NCT00812045

Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236

Phase 1

Completed

Posted: 2008/10/06

Sponsor:AstraZeneca

ID:NCT00767052

Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase 2

Completed

Posted: 2008/09/25

Sponsor:AstraZeneca

ID:NCT00758459

A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase 2

Completed

Posted: 2008/09/25

Sponsor:AstraZeneca

ID:NCT00758706

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy